title: Anti-Aβ antibody target engagement: a response to Siemers et al.
authors.affiliation: Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Melbourne, VIC, 3010, Australia.
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Watt
authors.forename: Gabriela A N
authors.initials: GA
authors.lastname: Crespi
authors.forename: Russell A
authors.initials: RA
authors.lastname: Down
authors.forename: David B
authors.initials: DB
authors.lastname: Ascher
authors.forename: Adam
authors.initials: A
authors.lastname: Gunn
authors.forename: Keyla A
authors.initials: KA
authors.lastname: Perez
authors.forename: Catriona A
authors.initials: CA
authors.lastname: McLean
authors.forename: Victor L
authors.initials: VL
authors.lastname: Villemagne
authors.forename: Michael W
authors.initials: MW
authors.lastname: Parker
authors.forename: Kevin J
authors.initials: KJ
authors.lastname: Barnham
authors.forename: Luke A
authors.initials: LA
authors.lastname: Miles
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D000818:Animals; D000906:Antibodies / Q000378:metabolism*; D005260:Female; D006801:Humans; D018697:Nootropic Agents / Q000494:pharmacology*
chemical_list: D016229:Amyloid beta-Peptides; D000906:Antibodies; D018697:Nootropic Agents